To investigate the response of Prp19 to DNA damage agents in HCC cells with mutated p53, Huh7 cells, expressing mutated p53 [15], was treated with CDDP at different time intervals with different doses. This evidence concerns the gene PRPF19 and hepatocellular carcinoma.